SAVE THE DATE! Putting the Patient in Patient-Focused Drug Development: A Briefing for the 114th Congress
Join Parent Project Muscular Dystrophy and other key stakeholders for a lunch briefing on what does – and does not – qualify as meaningful patient engagement and what we want to see from FDA to ensure that the patient voice is being heard and considered.
When: Tuesday, February 24th — 11:30 a.m. to 12:30 p.m. ET
Where: Kennedy Caucus Room — SR385 Russell Senate Office Building, Washington, D.C.
Lunch will be served
RSVP to Charla Ramsey at email@example.com by Friday, February 20th.